Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 10:25
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
SOLVEX Sees Significant Shift in Key Metrics, With Gross Margin Accelerating to 10.38% and Marginal Operating Leverage Rising Sharply to 2.55%.
The company's daily volume has also accelerated, increasing by from 7819 shares, while the close price remained flat at .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 10.38 % | 2.55 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.55 % | 0.05 | ▲ |
| REVENUE_GROWTH_YOY | 26.3 % | — | - |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 12,800 shares | 7,819 | ▲ |
| CLOSE_PRICE | 14.52 INR | 14.52 | - |
Cite this
Source: Samhati evidence synthesis for SOLVEX (2026-10-20). Observation: SOLVEX Sees Significant Shift in Key Metrics, With Gross Margin Accelerating to 10.38% and Marginal Operating Leverage Rising Sharply to 2.55%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/solvex
Filing step-changes